{'fraction_non_alphanumeric': 0.029918404351767906, 'fraction_numerical': 0.019038984587488667, 'mean_word_length': 5.381502890173411, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 2, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Migraine is common in patients with sarcoidosis

Objective To describe the frequency of migraine and predictors of having migraine in sarcoidosis patients. Methods The ID migraine questionnaire was administered to a well-phenotyped observational cohort of sarcoidosis patients (most of whom were seeking specialty care) and healthy controls. Predictors of migraine status were examined using univariate and multivariable logistic regression. Results Migraine was seen in 29% of 96 patients with sarcoidosis and 13% of 39 healthy controls, (p = 0.049). Among those with sarcoidosis, in univariate regression analysis only female sex was predictive of having migraine, and in a multivariable regression female sex remained significant (OR 4.6, 95% CI 1.2–18.2). There was no association between migraine and age, depression, dyspnea, immunosuppression use, or ESR. Conclusions Migraine is a common comorbidity in sarcoidosis patients. As such, better recognition and targeted treatment of migraine has the potential to improve quality of life as part of a comprehensive care plan for sarcoidosis patients.